本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Taysha Gene Therapies, Inc.

4.52
-0.0150-0.33%
成交量:140.85萬
成交額:635.24萬
市值:12.37億
市盈率:-13.44
高:4.60
開:4.49
低:4.44
收:4.53
52周最高:6.02
52周最低:1.05
股本:2.74億
流通股本:1.84億
量比:1.82
換手率:0.77%
股息:- -
股息率:- -
每股收益(TTM):-0.3359
每股收益(LYR):-0.3570
淨資產收益率:-64.93%
總資產收益率:-25.70%
市淨率:5.65
市盈率(LYR):-12.65

資料載入中...

2026/02/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/06

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/11/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/04

重要事件披露

Form 8-K - Current report
2025/11/04

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/10/17

重要事件披露

Form 8-K - Current report
2025/10/09

重要事件披露

Form 8-K - Current report